The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn; Chamberland, Mary E.; McClung, Nancy; Campos‐Outcalt, Doug; Morgan, Rebecca L.; Mbaeyi, Sarah; Romero, José R.; Talbot, H. Keipp; Lee, Grace M.; Bell, Beth P.; Dooling, Kathleen

doi:10.15585/mmwr.mm6950e2

articleMMWR Morbidity and Mortality Weekly ReportDec 13, 2020DIAMOND OA

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

SESara E. Oliver JWJulia W. Gargano MMMona Marin MWMegan Wallace KCKathryn Curran

PubMed

Indexed incrossrefpubmed

Abstract

The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines (2). The ACIP recommendation for the use of the Pfizer-BioNTech COVID-19 vaccine under EUA is interim and will be updated as additional information becomes available.

Citation impact

561

total citations

FWCI: 12.68
Percentile: 100%
References: 2

Citations per year

Authors

15

Topics & keywords

Topics

Keywords

Medicine
Interim
Advisory committee
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Immunization
Virology

No related works found for this paper.